Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study

被引：0
|
作者：
Cavusoglu, Y. [1 ]
Korkmaz, S. [2 ]
Demirtas, S. [2 ]
Gencer, E. [3 ]
Sasmaz, H. [4 ]
Mutlu, F. [1 ]
Yilmaz, M. B. [5 ]
机构：
[1] Eskisehir Osmangazi Univ, Eskisehir, Turkey
[2] Ufuk Univ, Fac Med, Ankara, Turkey
[3] Kilis State Hosp, Dept Cardiol, Kilis, Turkey
[4] Turkiye Yuksek Ihtisas Hosp, Ankara, Turkey
[5] Cumhuriyet Univ, Dept Cardiol, Sivas, Turkey
来源：
EUROPEAN HEART JOURNAL | 2013年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1064 / 1065
页数：2
相关论文
共 50 条
  • [1] Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study
    Cavusoglu, Yuksel
    Korkmaz, Sule
    Demirtas, Selda
    Gencer, Erkan
    Sasmaz, Hatice
    Mutlu, Fezan
    Gunes, Hakan
    Mert, Ugur Kadir
    Ozdemir, Sedat
    Kalayci, Suleyman
    Yilmaz, Mehmet Birhan
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2015, 15 (08): : 611 - 617
  • [2] Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study
    Cavusoglu, Yuksel
    Korkmaz, Sule
    Demirtas, Selda
    Gencer, Erkan
    Sasmaz, Hatice
    Mutlu, Fezan
    Yilmaz, Mehmet Birhan
    [J]. JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : S12 - S12
  • [3] Ischemia-Modified Albumin Levels in Patients with Acute Decompensated Heart Failure Treated with Dobutamine or Levosimendan: IMA-HF Study
    Cavusoglu, Yuksel
    Korkmaz, Sule
    Demirtas, Selda
    Gencer, Erkan
    Sasmaz, Hatice
    Mutlu, Fezan
    Yilmaz, Mehmet Birhan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C73 - C73
  • [4] Ischemia-Modified Albumin in Acute Decompensated Heart Failure: IMA-HF Study
    Cavusoglu, Yuksel
    Korkmaz, Sule
    Demirtas, Selda
    Gencer, Erkan
    Sasmaz, Hatice
    Yilmaz, Birhan
    [J]. CIRCULATION, 2012, 126 (21)
  • [5] Ischemia-modified albumin in patients presenting with acute decompensated heart failure: IMA-HF study
    Cavusoglu, Yuksel
    Korkmaz, Sule
    Demirtas, Selda
    Gencer, Erkan
    Sasmaz, Hatice
    Mutlu, Fezan
    Yilmaz, Mehmet Birhan
    [J]. CARDIOVASCULAR THERAPEUTICS, 2012, 30 : 31 - 31
  • [6] Role of ischemia-modified albumin in patients with acute decompensated heart failure
    Pan, Defeng
    Li, Dongye
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2015, 15 (08): : 618 - 619
  • [7] Levosimendan Plus Dobutamine in Acute Decompensated Heart Failure Refractory to Dobutamine
    Juguet, William
    Fard, Damien
    Faivre, Laureline
    Koutsoukis, Athanasios
    Deguillard, Camille
    Mongardon, Nicolas
    Mekontso-Dessap, Armand
    Huguet, Raphaelle
    Lim, Pascal
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 11
  • [8] Ischemia-modified albumin (IMA) levels predict long-term outcome in patients with acute myocardial infarction
    Van Belle, E.
    Dallongeville, J.
    Vicaut, E.
    Rouanet, S.
    Baulac, C.
    Montalescot, G.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 634 - 634
  • [9] Effects of Levosimendan and Dobutamine on Systolic Time Intervals in Patients with Acute Decompensated Heart Failure
    Cavusoglu, Yuksel
    Nadir, Aydin
    Mert, Kadir Ugur
    Gencer, Erkan
    Morrad, Bektas
    Mutlu, Fezan
    Ulus, Taner
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : C102 - C102
  • [10] Levosimendan vs dobutamine for patients with acute decompensated heart failure - The SURVIVE randomized trial
    Mebazaa, Alexandre
    Nieminen, Markku S.
    Packer, Milton
    Cohen-Solal, Alain
    Kleber, Franz X.
    Pocock, Stuart J.
    Thakkar, Roopal
    Padley, Robert J.
    Poder, Pentti
    Kivikko, Matti
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (17): : 1883 - 1891
12345